Usted buscó: negleforandringer (Danés - Inglés)

negleforandringer
nail disorders.

der er set hår - og negleforandringer.
hair and nail changes have been observed.

hudpigmentering (farvning), og negleforandringer;
pigmentation (colouring), and nail disorder;

hudforandringer som rødme, kløe og negleforandringer
kin changes such as redness and itching of the skin, nail changes

almindelig: pruritus, tør hud, negleforandringer, flushing
common: pruritus, dry skin, nail disorder, flushing

negleforandringer, såsom forandringer i neglelejet, neglesmerter, betændte og hævede neglebånd
nail disorders such as nail bed changes, nail pain, infection and swelling of the cuticles

alvorlige negleforandringer er karakteriseret ved hypo- eller hyperpigmentering og sommetider smerter og onykolyse.
severe nail disorders are characterised by hypo- or hyperpigmentation and sometimes pain and onycholysis.

negleforandringer, pruritus, tør hud, erythem, misfarvning af negle, hyperpigmentering af hud, onycholyse
hepatobiliary disorders reproductive system and breast disorders:

svære negleforandringer er karakteriseret ved hypo- eller hyper-pigmentering og sommetider smerter og onykolyse.
severe nail disorders are characterised by hypo- or hyperpigmentation and sometimes pain and onycholysis.

betændelse i hårfollikler, skællende hud, betændelse eller udslæt, unormal hudpigmentering (farvning), og negleforandringer.
inflammation of hair follicles, scaly skin, inflammation or rash, abnormal skin pigmentation (colouring), and nail disorder;

almindelig: negleforandringer, pruritus, tør hud, erytem, misfarvning/pigmentering af negle, hyperpigmentering af hud, onykolyse, negleændringer
common: nail disorder, pruritus, dry skin, erythema, nail pigmentation/discolouration, skin hyperpigmentation, onycholysis, nail changes

blandt de patienter, der fik docetaxel hver tredje uge, var hyppigheden af relaterede negleforandringer 10% højere i patientgruppen på 65 år og derover, end i gruppen af yngre patienter.
in patients treated with docetaxel every three weeks, the incidence of related nail changes occurred at a rate 10% higher in patients who were 65 years of age or greater compared to younger patients.

for de toksiciteter, for hvilke den behandlende læge anser det for usandsynligt, at disse kan udvikle sig til at blive alvorlige eller livstruende, som f.eks. alopeci, smagsændringer og negleforandringer, kan behandlingen fortsættes med uændret dosis uden dosisreduktion eller behandlingsafbrydelse.
for those toxicities considered by the treating physician to be unlikely to become serious or life-threatening, e.g. alopecia, altered taste, nail changes, treatment can be continued at the same dose without reduction or interruption.